Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by BioTeckon May 24, 2022 1:34pm
157 Views
Post# 34704166

RE:RE:Asks

RE:RE:AsksIf youre on the fence it might be wise to wait and see if buying actually comes in.  It'll be easy to spot and might be worth risking a few percent gains and catch it on the way up. It'll be easy to sweep up some crumbs which is what most retailers are looking for.



If you like the story, have patience and have money collecting dust, then I'd consider buying now. You will likely not lose in the long run and the cheapest you'll realistically be able to get a good amount of shares for is about 1.50.



The stock won't be uplisting for at least a week and the clinical update isn't until June so you have a few days to assess the situation. If the general markets don't tank, I don't see the price drifting down past 1.45. 



All just my opinion. 






Stockfshr wrote: Will be interesting to see if those big buyers materialize when we begin trading on the TSX. For those that believe they will, then buying now in anticipation would be the thing to do.


<< Previous
Bullboard Posts
Next >>